Impact of trophectoderm biopsied cell number on the assay quality of preimplantation genetic testing for aneuploidy
Reproductive BioMedicine Online · 2025
DOI: 10.1016/j.rbmo.2025.105407 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Reproductive BioMedicine Online, 2025. Verfasst von Chiao-Hsin Kung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Genetic Testing, Specimen Handling, Preimplantation Diagnosis, Aneuploidy. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Kaohsiung Chang Gung Memorial Hospital.
Abstract (Originalsprache)
RESEARCH QUESTION: Does the number of trophectoderm cells biopsied during blastocyst-stage preimplantation genetic testing for aneuploidy (PGT-A) affect diagnostic or clinical outcomes? DESIGN: This retrospective study included 660 blastocysts from 222 cycles, grouped according to the number of cells biopsied (two to four, five to six, seven or more). Next-generation sequencing (NGS) was used for genetic analysis. Diagnostic failure, aneuploidy, mosaicism, re-expansion and implantation rates were compared between the groups. Multivariable logistic regression adjusted for age, embryo quality, and morphological grade of trophectoderm cells. RESULTS: Diagnostic failure and mosaicism rates did not differ significantly between the groups. The aneuploidy rate differed significantly between the 2-4-, 5-6-, and ≥7-cell groups (56.7%, 43.1% and 57.8%, respectively; P = 0.010); this was associated with maternal age ≥35 years (adjusted OR 2.34, 95% CI 1.59-3.45; P 98%, and the implantation rate was similar across the groups. CONCLUSIONS: Diagnostic failure rates may be comparable when different numbers of trophectoderm cells are biopsied, after adjustment for potential confounders in multivariable analyses. Minimizing the number of cells biopsied may reduce embryo injury, supporting the need for standardized biopsy protocols that consider both diagnostic yield and embryo preservation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- Department of Obstetrics and Gynaecology, Chia-Yi Chang Gung Memorial Hospital, Chia-Yi, Taiwan.
- Department of Obstetrics and Gynaecology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; Department of Obstetrics and Gynaecology, Xiamen Chang Gung Hospital, Xiame…
- Department of Obstetrics and Gynaecology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan; School of Medicine, College of Medicine, National Sun Yat-sen University, K…
Förderung
- Kaohsiung Chang Gung Memorial Hospital
Zitieren
APA
Kung, C. H., Chen, C. M., Tsai, N. C., Su, Y. T., Lin, Y. J., Kung, F. T., & Lan, K. C. (2025). Impact of trophectoderm biopsied cell number on the assay quality of preimplantation genetic testing for aneuploidy. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2025.105407
Vancouver
Kung CH, Chen CM, Tsai NC, Su YT, Lin YJ, Kung FT, et al. Impact of trophectoderm biopsied cell number on the assay quality of preimplantation genetic testing for aneuploidy. Reproductive BioMedicine Online. 2025. doi:10.1016/j.rbmo.2025.105407
BibTeX
@article{Kung2025,
author = {Kung, Chiao-Hsin and Chen, Che-Min and Tsai, Ni-Chin and Su, Yu-Ting and Lin, Yu-Ju and Kung, Fu-Tsai and Lan, Kuo-Chung},
title = {Impact of trophectoderm biopsied cell number on the assay quality of preimplantation genetic testing for aneuploidy},
journal = {Reproductive BioMedicine Online},
year = {2025},
doi = {10.1016/j.rbmo.2025.105407}
}
EUVIMED